CD276 and exocrine pancreatic carcinoma: To study the possible involvement of B7-H3 in the sensitivity of pancreatic carcinoma cells to gemcitabine, shRNA was used to create a stable B7-H3 knockdown cell variant derived from the Patu8988 cell line.